- Home
- QLGN vs RVYL Comparison
QLGN vs RVYL Comparison
Compare QLGN & RVYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QLGN
- RVYL
- Stock Information
- Founded
- QLGN 1996
- RVYL 2007
- Country
- QLGN United States
- RVYL United States
- Employees
- QLGN N/A
- RVYL N/A
- Industry
- QLGN Biotechnology: Pharmaceutical Preparations
- RVYL Professional Services
- Sector
- QLGN Health Care
- RVYL Consumer Discretionary
- Exchange
- QLGN Nasdaq
- RVYL Nasdaq
- Market Cap
- QLGN 7.4M
- RVYL 7.3M
- IPO Year
- QLGN N/A
- RVYL N/A
- Fundamental
- Price
- QLGN $3.06
- RVYL $0.43
- Analyst Decision
- QLGN
- RVYL Hold
- Analyst Count
- QLGN 0
- RVYL 1
- Target Price
- QLGN N/A
- RVYL N/A
- AVG Volume (30 Days)
- QLGN 3.7M
- RVYL 21.6M
- Earning Date
- QLGN 11-13-2025
- RVYL 11-13-2025
- Dividend Yield
- QLGN N/A
- RVYL N/A
- EPS Growth
- QLGN N/A
- RVYL N/A
- EPS
- QLGN N/A
- RVYL N/A
- Revenue
- QLGN N/A
- RVYL $48,904,000.00
- Revenue This Year
- QLGN N/A
- RVYL $27.50
- Revenue Next Year
- QLGN N/A
- RVYL $35.71
- P/E Ratio
- QLGN N/A
- RVYL N/A
- Revenue Growth
- QLGN N/A
- RVYL N/A
- 52 Week Low
- QLGN $1.61
- RVYL $0.25
- 52 Week High
- QLGN $8.81
- RVYL $2.33
- Technical
- Relative Strength Index (RSI)
- QLGN 40.62
- RVYL 61.93
- Support Level
- QLGN $2.90
- RVYL $0.30
- Resistance Level
- QLGN $5.97
- RVYL $0.39
- Average True Range (ATR)
- QLGN 0.54
- RVYL 0.04
- MACD
- QLGN -0.20
- RVYL 0.01
- Stochastic Oscillator
- QLGN 5.21
- RVYL 93.18
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.
About RVYL Ryvyl Inc.
Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.